Developments in prognostic factors of acute myeloid leukemia (AML)
Gert J. Ossenkoppele
Marginalized and high-risk multiple myeloma patients: how to address this issue
How does a patient’s personal situation affect CLL treatment choice?
Progress in acute myeloid leukemia treatment – collaborating to develop targeted therapies
The current status of CLL treatment and how clinical practice will change